The first needle-free adrenaline treatment launches in the UK, validating non-invasive delivery with real-world data ...
Biopharma data showed M&A strength, selective venture capital favoring Phase II, record obesity deals, and significant ...
M&A favors late-stage assets, obesity deals surge, AI accelerates manufacturing, and policy drives strategic US facility ...
As the conference approaches, scientists are reviewing new technologies that enhance manufacturing process control, product ...
Michael Ritchie, chief commercial officer at Champions Oncology, explains what makes radiopharmaceuticals unique in the treatment of cancer.
Advanced biotech equipment, driven by R&D investment and personalized medicine, is essential for scalable drug production and ...
This article outlines common CMC problems that are obstacles that steal momentum and create costly detours in the development ...
ICE Pharma will present its bile acid-derived innovations and sustainability strategies at CPHI Frankfurt 2025. The company's ...
The EU's life science strategy aims to enhance public health, create jobs, and foster innovation by 2030, positioning the EU ...
Life sciences CEOs are boosting AI spending, focusing on workforce upskilling, and tackling ethical challenges to drive innovation and product development.
Excipient World is the only US event focused exclusively on excipients. Join professionals from pharmaceutical, bio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results